Pre-budget survey shows increasing demand for making investments more attractive in pharma sector
Advertisement
New Delhi: A pre-budget expectations survey showed increasing demand for making investments more attractive in the pharmaceutical industry.
As per the Grant Thornton Bharat survey, a majority of those surveyed opined that the government should enhance outlay in the PLI scheme, with a focus on bio-pharmaceuticals and medical devices.
"The industry expects that innovation and research & development (R&D) will be the key investment drivers," the survey report said.
"Restoration of a higher percentage of deduction under Section 35(2AB) of the Income-tax Act, 1961 will encourage R&D and innovation."
Notably, 85 per cent of the respondents expect restoration of a higher percentage of deduction under Section 35(2AB) of the Income-tax Act, 1961 for R&D expenditure. Besides, 81 per cent expect pharmaceutical products to be included in the 'RoDTEP' scheme.
"Inclusion of certain pharmaceutical products under the 'Remission of Duties and Taxes on Export Products' (RoDTEP) scheme, amendment of regulations around deductibility of free samples given to doctors and a lower Good and Services Tax (GST) rate on clinical trials and research activities will be a welcome move."
According to Bhanu Prakash Kalmath S.J., Partner and Sector Leader - Pharma & Healthcare, Grant Thornton Bharat: "India's pharmaceutical industry has played a key role in the global fight against the pandemic."
"Enhanced outlay under the PLI schemes and encouraging exports and research & development will further advance the 'Make in India' vision and consolidate our position as a leading pharmaceutical supplier."
Read also: Research, Innovation necessity for sustained growth of pharma sector: Mandaviya
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.